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Introduction: Gout is an inflammatory condition induced by the deposition of monosodium urate (MSU)
crystals in the joints and soft tissues that can produce acute or chronic arthritis. Several animal models of
crystal-induced inflammation have been proposed that involve direct injection of MSU-crystals into different
anatomical structures; however, only a few of these models reflect a true diarthrodial joint microenvironment in
which an acute gouty attack takes place. The aim of this study was to assess the inflammatory and structural
joint changes in a rabbit model of acute gout attack by ultrasound (US), synovial fluid (SF) and histopathological
analyses.
Methods: Under US guidance, 42 rabbit knees were randomly injected with a suspension of 50 mg/ml of either MSU
or allopurinol synthetic crystals. The control group received intra-articular vehicle of phosphate-buffered saline
(PBS). US evaluation, SF and histopathological analyses were performed at days 1, 3, and 7.
Results: A total of 21 rabbit knees were assigned to the control group, 12 to the MSU-crystals group, and 9 to
the allopurinol crystals group. By US, the MSU crystals group displayed the double contour sign and bright stippled
aggregates in 67% and 75% of joints, respectively. Neither control knees nor allopurinol crystals group displayed these
US signs. Power Doppler (PD) signal was moderate to intense in the MSU-crystals group and greater than both the
allopurinol crystal and control groups at day 1 (P <0.001) and 3 (P <0.05), with its practical disappearance by day
7. SF leukocyte count was 40,312 ± 6,369 cells/mm3 in the MSU-crystals group, higher than in controls (P = 0.004)
and allopurinol crystal group (P = 0.006). At day 7, SF leukocyte count decreased in both MSU and allopurinol
crystal groups reaching the non-inflammatory range. Histologically, at day 3 intense synovial polymorphonuclear
cells infiltration and MSU aggregates were identified.
Conclusion: The rabbit model of MSU crystal-induced acute arthritis efficiently reproduces the inflammatory,
US, SF and histopathological changes of the human acute gouty attack.* Correspondence: allorey@yahoo.com
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Gout is an inflammatory condition induced by the de-
position of monosodium urate (MSU) crystals in joints
and soft tissues that can produce an acute or chronic
arthritis [1]. The early phase of MSU-induced inflamma-
tion is associated with activation of the NACHT, LRR
and PYD domain-containing protein 3 (NALP3) inflam-
masome or cryopyrin, triggering the release of IL-1β and
IL-18 [2], thus promoting cellular activation, cytokine
and chemokine production, and infiltration of neutro-
phils, leading to an acute gouty attack [3,4]. Despite their
similar morphology, allopurinol crystals have not been
found to activate the NALP3 inflammasome [5].
Several animal models of crystal-induced inflammation
have been studied that involve direct injection of MSU crys-
tals into both intra-articular and extra-articular locations.
Extra-articular locations include: intradermal, subcutaneous,
and intraperitoneal areas; however, only the intra-articular
model reflects the true diarthrodial joint microenvironment,
in which an acute gouty attack takes place [6-16].
Imaging techniques such as ultrasound (US) may reinforce
the diagnosis, monitoring, and management of gout [17-19].
Several studies have shown its capability to detect both
intra- and extra-articular abnormalities in patients with
gout [20-28]. The high reflectivity of MSU-crystal ag-
gregates, and the ability of US to detect even minimal
MSU-crystal deposits explain the high sensitivity of US
for revealing MSU deposits [26]. To our knowledge no
animal model has been used to sequentially evaluate
the changes of MSU crystal-induced acute arthritis,
using a multimodality approach including US as an im-
aging tool. Thus, the aim of this study was to assess the
spatial and temporal joint changes in a rabbit model of
acute MSU crystal-induced arthritis by US, synovial fluid
(SF) cell counts, and histopathological analyses.
Methods
Study subjects
A total of 21 male adult white New Zealand rabbits weighing
2 kg, were acclimatized to the animal facility environment
during 1 week prior to the study. The rabbits were housed
with a standard diet, and circadian rhythm synchronized
with a 12-h:12-h light-dark cycle. This protocol was
approved by the Ethics and Research Committee of the
Instituto Nacional de Rehabilitación (reference EP/01-12),
and experiments were performed in accordance with
current ethics guidelines and the Institutional Animal
Care and Use Committee (reference BIO/01/12). All
procedures were in accordance with the guidelines of the
Official Mexican Standard NOM-062-ZOO-1999 [29].
Synthetic MSU and allopurinol crystal preparation
MSU and allopurinol crystals were prepared using
the Denko and Whitehouse method [30] modified byScanu et al. [3]. Crystals were sterilized at 180°C and
suspended in sterile PBS at a concentration of 50 mg/ml.
The morphological and birefringence properties of MSU
and allopurinol crystals were assessed by standard
light, polarized light and scanning electron microscopy
(Additional file 1). The MSU crystals were uniform in size
(12 ± 2 μm in length), needle-shaped, and exhibited nega-
tive birefringence. The absence of microbial contaminants
was confirmed by negative cultures for microorganisms
and were bacterial endotoxin-free (<0.01 EU) by the
Limulus amebocyte cell-lysate assay (Sigma®, St Louis,
MO, USA).
Animal model and study design
At baseline (day 0), US examinations of 42 rabbit knee
joints were performed. Each animal was then sedated
with 6.5% pentobarbital sodium solution intravenously.
Under US guidance, one knee was intra-articularly injected
with 1 ml of PBS (control group), while the contralateral
joint was randomly injected with 1 ml of a suspension con-
taining 50 mg/ml of either MSU or allopurinol crystals
(Figure 1). At days 1, 3, and 7, US scans, US-guided arthro-
centesis, and SF analysis were obtained from all injected
joints. At the end of each time point, animals were eutha-
nized and tissue samples were obtained for histological
analysis.
Ultrasound assessment and interpretation
US scans were performed using a MyLab25® device
(Esaote Biomedica, Genoa, Italy) equipped with a high-
frequency (10 to 18 MHz) linear array transducer. The
power-Doppler (PD) technique was used to detect blood
flow. PD settings included: pulse repetition frequency of
700 Hz, Doppler frequency of 7.1 MHz, low wall filter, and
Doppler gain adjusted to avoid random noise visualization.
All US examinations were performed by two experienced
sonographers (CHD and LV), who were blinded to the
injection type at all time points. Before the study, the
sonographers reached consensus on the scanning tech-
nique to adopt and the gout-related US findings to
evaluate. Rabbit knees were scanned using a multipla-
nar technique. The insonation angle was adjusted in
order for it to be perpendicular to the cartilage surface.
B-mode gain was initially set in order to obtain maximal
contrast among tissues and was successively reduced to its
lowest level, allowing only visualization of hyperechoic
structures, using the bony cortex as reference.
The presence of US-defined synovial effusion and syn-
ovial hypertrophy was based on Outcome Measures in
Rheumatology (OMERACT) definitions [31]. The pres-
ence of intra-articular PD signal was graded on a semi-
quantitative scale (0 to 3) as previously described [32].
The following US features of MSU-crystal deposition
were assessed: the double contour sign (DCS) and bright
Figure 1 Schematic diagram of the study protocol. MSU, monosodium urate.
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scribed as among the most frequently identified elemen-
tary lesions of gout [27]. The DCS is defined as an
abnormal hyperechoic band over the superficial margin
of the articular cartilage. To further distinguish DCS
from the cartilage interface sign, dynamic testing was per-
formed. BSA is defined as intra-articular heterogeneous
hyperechoic foci with or without posterior shadowing over
a hypo- or anechogenic background. Finally, all US images
were interpreted in conjunction with a third, blinded, ex-
perienced sonographer (CP). Discrepancies were resolved
by consensus among the three sonographers.
Synovial fluid analysis
At days 1, 3, and 7, US-guided arthrocentesis of both
control and crystal-injected knees were performed [33].
SF aspirates were evaluated under standard light and po-
larized light microscopy to assess the presence, morph-
ology, and birefringence of crystals. SF leukocyte count
was performed using a Neubauer chamber.
Histological assessment
Histological evaluation was performed at days 1, 3, and
7. All knee joints were dissected, a gross pathological
examination was carried out and then fixed in 100% al-
cohol for 24 h; then decalcified in 5% nitric acid-ethanol
for 48 h, and embedded in paraffin. Tissue sections(4 μm) were stained with H&E to assess inflammatory
cell infiltrates; safranin-O dye was used to assess cartil-
age proteoglycan content, and eosin Y solution 0.5%
alcohol, to prevent the dissolving of MSU crystals and
preserve their birefringence properties [34,35].
Statistical analysis
Data were expressed as mean ± standard error of the
mean (SEM). Statistical significance between the groups
was assessed by two-tailed analyses using GraphPad
Prism 6.0 for Windows. Frequencies and proportions
were expressed as percentages to describe categorical
data, and differences were analyzed using the Fisher exact
test. The Mann-Whitney U-test and two-way analysis
of variance were computed for continuous variables.
A P-value <0.05 was considered significant.
Results
Twenty-one knee joints were assigned to the control
group, and randomization resulted in a total of 12 knees
in the MSU-group and nine in the allopurinol crystals
group (Figure 1).
Ultrasound findings
At baseline prior to joint injections neither US gray-
scale abnormalities indicating MSU deposition nor intra-
articular PD signals were detected. All intra-articular
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guidance. In the MSU-crystals group DCS was present
in 8 of 12 (67%) knee joints. Chronologically, the DCS
sign appeared as early as day 1 in two of the four evalu-
ated knees; at day 3 it became apparent in three more
knees, and finally at day 7 in three additional knees. The
BSA was found in 9 of the same 12 (75%) MSU-injected
knee joints which contemporaneously exhibited this US
sign (Figure 2). Neither control knees nor allopurinol crystal
group showed either DCS or BSA sonographic signs.
Regarding intra-articular blood flow, a moderate to in-
tense increase in synovial vascularity was observed in
the MSU-crystal group; PD signal intensity was greater
compared to the control group at days 1 (P <0.01) and 3
(P <0.05). At day 7 a decrease in synovial perfusion (PD
signal intensity) was observed in the MSU-crystal group
(Figure 3). When comparing MSU-injected joints to those
of the allopurinol crystal group, a significant increase in
PD signal intensity in the MSU group was also found at
day 1 (P = 0.026).
Synovial fluid analysis
SF aspirates at day 1 revealed the presence of numerous
negatively birefringent needle-shaped crystals in the
MSU-crystal group; the majority of crystals were extra-
cellularly located while a minority were phagocytized
by polymorphonuclear cells. Mean white-cell count in
the MSU-crystal group was 40,312 ± 6,369 cells/mm3;Figure 2 Longitudinal ultrasound images of the rabbit knee joints at day
images of the monosodium urate (MSU)-crystal group: (B) double contour sign (
power-Doppler signal.this cell count was significantly higher than in the control
group (1,687 ± 1,303 cells/mm3; P = 0.004) as well as in
the allopurinol-crystal group (9,050 ± 2,477 cells/mm3;
P = 0.006). However, when comparing SF cell counts
from the allopurinol-crystal group with those of the
control group, there was no significant difference. In
comparison to day 1 the SF cellular content from both
the MSU and allopurinol crystal groups decreased at
day 3 to 12,075 ± 9,545 and 605 ± 75 cells/mm3, re-
spectively. It was noteworthy that at day 3, SF from the
MSU-crystal group displayed giant multivacuolated
cells [36], cellular debris, crystal fragments phagocytized
by polymorphonuclear cells, and scarce extracellular
crystals. At day 7, SF leukocyte counts decreased in
both the MSU and allopurinol crystal groups within
the non-inflammatory range (to 566 ± 300 cells/mm3
and 316 ± 145 cells/mm3, respectively), and no crystals
were observed by polarizing microscope examination
(Figures 4 and 5).
Histological analysis
Evaluation of the gross anatomic examination of the
MSU-crystal injected knee joints showed MSU crystals
forming white aggregates on the surface of the articular
cartilage. Histological analysis of the MSU-crystal group
showed focal synovial hyperplasia, mild reactive changes,
vessel congestion, and patchy acute inflammatory cellular
infiltrates at day 1. In addition scarce synovial membrane1. (A) Control group showing no abnormalities. (B, C, D) Representative
DCS) (arrow); (C) bright stippled aggregates (BSA) (arrows); (D) intra-articular
Figure 3 Semiquantitative power-Doppler (PD) score for rabbit knees injected with monosodium urate (MSU), allopurinol and control
groups. At days 1 and 3 an increase in PD signal intensity in the MSU crystal group was found when compared to the control group (**P <0.01
and *P <0.05, respectively). Additionally, a significant increase of PD signal was present when comparing the MSU to the allopurinol crystal
groups (#P <0.05).
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By day 3 a thickened and hyperplastic synovium, large
synovial MSU-crystal clusters, and intense polymorpho-
nuclear cell infiltration, in addition to some plasma cells
and macrophages, were identified. At day 7 the MSU-
crystals group showed scattered, small-sized microcrystal-
line aggregates and focal neutrophilic infiltrates consistent
with mild and focal acute synovitis. Evaluation of cartilage
proteoglycans showed no abnormalities in the content
and distribution of sulfated proteoglycans in any of the
study groups. No histological abnormalities were observed
in the allopurinol crystal or control groups. However,
histological sections of the articular cartilage failed toFigure 4 Synovial fluid leukocyte cell count from rabbit knees
in the monosodium urate (MSU), allopurinol and control
groups. A significant increased cell count was present at days 1 and
3 in the MSU-crystal group when compared to PBS (**P <0.01) and
allopurinol crystal groups (##P <0.01).demonstrate deposition of MSU-crystals as seen in the
gross anatomical specimens.
Discussion
This study sequentially evaluated the temporal and spatial
ultrasonographic, inflammatory, and structural joint
changes observed in an animal model of acute gouty
attack, by applying a multimodality approach.
In the past, a variety of animal models have been used
to study the acute inflammatory response in crystal-
induced arthritis [10-13]. Faires and McCarty reproduced
an acute gouty episode by injecting 20 mg of MSU crystals
into their own knees and into a canine animal model [14].
Subsequently, murine models of peritoneal [7,11] and
subcutaneous air-pouch cavity of MSU-crystals have
been utilized to study the inflammatory response [7,18].
Torres et al. [37] evaluated behavioral changes in mice
after an intra-articular injection of MSU crystals and
quantified systemic inflammatory biomarkers. An adult
Japanese female rabbit model was used by Nishimura
et al. [38] to evaluate the role of locally produced IL-8
in knee joints injected with MSU crystals.
On the other hand, contrast-enhanced US has been
employed to assess synovial vascularity in a rabbit knee
model of carrageenan-induced inflammatory arthritis [39].
To the best of our knowledge there are no animal models
that reported the use of US guidance to ensure proper
needle placement in their very small joint cavities, allow-
ing successful joint aspirations and injections, thus avoiding
damage to adjacent anatomic structures.
Using a multimodality approach to monitor the tem-
poral and spatial sonographic, inflammatory, and mor-
phostructural changes observed in a rabbit knee model
of acute gouty arthritis, we were able to reproduce two
Figure 5 Standard light and compensated polarized light microscopic analysis of synovial fluid (SF) from the monosodium urate (MSU)
and allopurinol groups. Observe the presence of intra- (arrows) and extra-cellular negatively birefringent needle-shaped crystals in the MSU-crystal
group at day 1. MSU crystals phagocytized by polymorphonuclear cells were seen at days 1 and 3. Absence of MSU and allopurinol crystals
was observed at day 7.
Figure 6 Histopathological analysis of rabbit knee joint injected with monosodium urate (MSU), allopurinol and control groups.
Hypertrophy, inflammatory cell infiltration and MSU crystal aggregates (arrows) were present in the synovium starting from day 1. No cartilage
abnormalities were observed at any time points.
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[17,23,27,40]. Our results provide gross pathological evi-
dence that the development of the characteristic sono-
graphic features of gout, DCS and BSA after synthetic
MSU-crystal injection, resulted from the precipitation of
MSU crystals on the superficial layer of the articular
cartilage and intra-articular soft tissues, respectively.
On the other hand, allopurinol crystals were used as a
negative, microcrystalline, control group, because previ-
ous reports have shown the failure of these crystals to
activate the NALP3 inflammasome [5,41]. US failed to
demonstrate the presence of DCS and BSA in the allo-
purinol crystal-injected animal. However, our results at
the joint level, showed a low-grade, limited, and transi-
ent inflammatory response demonstrated by mild intra-
articular PD signal plus an inflammatory range of SF
leukocyte cell counts.
By means of a multimodal approach, several temporal
and spatial, early, MSU-deposition, gouty changes were
observed in the rabbit knee model. DCS appeared in one
half of MSU-injected joints at day 1, and increased up to
75% at days 3 and 7, indicating that these crystals tend
to deposit very early in the initial acute, inflammatory
stages of disease, and not only in its late, chronic stages,
as previously proposed [1]. As expected, from the syn-
ovial vascularization perspective, PD signals appeared as
early as day 1, revealing hyperemia of synovial tissues in
acutely inflamed rabbit joints, followed by a gradual re-
duction in signal intensity at days 3 and 7, respectively.
These findings are consistent with the human counter-
part; as atypical acute gouty attack is self-limiting, it
peaks at 24 to 48 h after symptoms appear, and lasts 5
to 10 days [4]. US evaluations in the rabbit model failed
to show additional, previously reported, sonographic
findings in gouty patients, such as tophus, hyperechoic
cloudy areas, and/or erosions [27]. The absence of these
findings in our acute inflammatory animal model sug-
gests that an extended time period with MSU crystals
may be required to produce and display these elemen-
tary lesions as seen in gout on US.
A temporal correlation between SF cell counts and US
findings was found at all experimental study time points.
In contrast, histological findings were delayed in time
relative to the SF inflammatory changes. Total SF cell
counts from the MSU crystal group reached an inflam-
matory range that peaked at day 1. Despite the lack of
standard normal values reported for rabbit SF, the con-
trol group displayed cell counts <2,000 cells/mm3 that in
its human counterpart are considered non-inflammatory
[42]. At day 1 pleomorphic cells, consistent with macro-
phages, were observed. These resident macrophages and
infiltrating monocytes are responsible for initiating and
driving the early inflammatory phase of the acute gout at-
tack [7,43,44]. Histological assessment revealed markedsynovial lining hyperplasia following injection of MSU
crystals at days 3 and 7. Remarkably, only scattered in-
flammatory cells were observed infiltrating the synovium
of the MSU crystal group at day 1; notwithstanding this,
the number of inflammatory cells in the SF reached its
peak. However, intense infiltration of the synovial mem-
brane by polymorphonuclear leukocytes occurred only
until day 3.
Interestingly, the observation of an intense inflamma-
tory reaction spatially coincides with the detection of
giant macrophages in the SF. At day 7 histologic evalu-
ation revealed only focal neutrophilic infiltrates of the
synovial membrane that are consistent with mild and focal
synovitis, which correlates with the non-inflammatory SF
white-cell count observed at this time point. These find-
ings suggest that deposition of MSU crystal in the joint
space and synovial membrane elicits a strong inflamma-
tory reaction that promotes recruitment of a large number
of polymorphonuclear leukocytes to the SF within 24 h.
As the inflammatory response temporarily progresses, the
synovial membrane becomes hyperplastic and thickened
by widespread inflammatory cell infiltrates, resident mac-
rophages in the SF become active and start to phagocyte
MSU crystals, and polymorphonuclear leukocytes seg-
regate within the synovial membrane. This reaction is
self-limited and by day 7 the majority of MSU crystal de-
posits have been phagocytized, the SF becomes non-
inflammatory, and few leukocytes can be found within the
synovial membrane, with only mild synovitis. Visualization
of MSU crystals over the cartilage surface was accom-
plished by gross examination of the articular cartilage but
was not shown histologically. This discrepancy can be
explained by mechanical loss of the crystals by surgical
removal of the extremity, vibration of the band saw
and mechanical washing process resulting in MSU-
crystal loss [35].
Animal models of human illness provide invaluable
tools to understand the basic biological mechanisms for
identifying and validating novel molecular targets and
pathways involved in the pathogenesis of the disease, and
to identify potential therapeutic and preventive agents
[45]. The fact that the rabbit knees injected with MSU
crystals were the only ones to produce a severe inflamma-
tory synovial response and reproduced the typical US
findings of human gout, supports both the internal and
external validity of our animal model. The concurrent
validity of the animal model was established by dem-
onstrating US-detected abnormalities and the presence
of MSU crystals by both polarized light microscopy
and histological analysis as the gold standard.
Our study has several limitations. First, in contrast to
the systemic and local inflammatory process triggered by
the in-situ re-crystallization of endogenous MSU crystals
in the synovial membrane, our model responded with a
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ous synthetic MSU crystals. Second, clinical parameters
such as pain, temperature, swelling, behavioral testing,
and disability were not evaluated. Third, we only evalu-
ated intra-articular changes due to MSU-crystal injec-
tions within a limited time period (7 days); it would be
appropriate to monitor the intra-articular changes for a
longer period of time and/or recurrent MSU-crystal
injections.
Conclusions
In conclusion, our rabbit knee model of MSU crystal in-
duced effectively an acute joint inflammatory process, and
accurately depicted the early morphostructural changes ob-
served by US during an acute gouty attack. US, SF, and
histological analyses provide a working hypothesis: the
early presence of deposits and aggregates of MSU crystals
is critical in the acute disease phase, challenging the trad-
itional paradigm that this process was limited to the
chronic disease stages. The rabbit knee model of MSU
crystal-induced arthritis serves as an ideal temporal, spatial,
and multimodal platform for further study of the inflam-
matory process and for detecting structural changes at
the joint level during an acute episode of gouty arthritis.
Additionally, it affords the opportunity for testing of
different pharmacological strategies in the management
of gout.
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Additional file 1: Morphological and birefringence properties of
monosodium urate (MSU) crystals were assessed by polarized light
(400 ×) and scanning electron microscopy (50,000 ×).
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